At Idris Oncology, we are developing novel tools to aid clinicians in the diagnosis, treatment selection and monitoring of life-threatening diseases. Precision medicine has transformed cancer care. Therapies are now selected to specifically target molecular markers present within a patient's tumor. However, if you cannot see the target, how do you know what to aim for? Standard biopsies can give doctors this information, yet for too long they have been unreliable and often dangerous. Idris Oncology is committed to providing clinicians with the best tools to sample a patient's tumor cells and tumor cell products. Only with the best information can patients receive the best care. Find out more about our technology, visit www.idrisoncology.com
View Top Employees from Idris Oncology BVWebsite | http://www.idrisoncology.com |
Revenue | $4 million |
Employees | 12 (10 on RocketReach) |
Founded | 2016 |
Phone | +31 6 43163844 |
Technologies |
JavaScript,
HTML,
Twitter
+12 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Hospitals & Clinics, Healthcare |
SIC | SIC Code 801 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 621111 Companies, NAICS Code 621 Companies, NAICS Code 62111 Companies, NAICS Code 62 Companies, NAICS Code 6211 Companies |
Looking for a particular Idris Oncology BV employee's phone or email?
The Idris Oncology BV annual revenue was $4 million in 2024.
Peter Wiegman is the Co-founder of Idris Oncology BV.
10 people are employed at Idris Oncology BV.
The NAICS codes for Idris Oncology BV are [621111, 621, 62111, 62, 6211].
The SIC codes for Idris Oncology BV are [801, 80].